111, Inc. (YI), a Chinese digital healthcare platform that connects patients with healthcare services, on Thursday registered a wider net loss for the fourth-quarter, mainly due to a decline in revenue and increased costs and expenses.
For the three-month period, the company posted a net loss of RMB210.366 million, compared with a loss of RMB114.431 million, recorded for the same period of last year.
Loss per ADS was RMB2.48, wider than from last year's loss of RMB1.38 per ADS.
Excluding items, loss was at RMB59.014 million, wider than loss of RMB45.739 million a year ago.
Adjusted loss per ADS was RMB0.70, wider than last year's loss of RMB0.56 per ADS.
Loss before income taxes stood at RMB 205.072 million as against a loss of RMB104.076 million in 2022.
Loss from operations widened to RMB206.538 million from loss of RMB108.427 million in 2022.
Total operating costs and expenses were up at RMB4.315 billion from RMB4.256 billion a year ago.
Interest expense more than doubled at RMB5.616 million from last year's RMB2.777 million.
Revenue was RMB4.108 billion, down from RMB4.148 billion last year.
For comments and feedback: editorial@rttnews.com